Revivegen Co., Ltd.
Revivegen Co., Ltd. engages in the industrial waste treatment business in Taiwan. It is involved in the waste solvent physical treatment and thermal treatment activities; and provision of semiconductor cleaning agent, chip cleaning agent, paint and coating additives, and lithium battery auxiliary materials. Revivegen Co., Ltd. was founded in 2010 and is headquartered in Tainan City, Taiwan.
Revivegen Co., Ltd. (7578) - Total Liabilities
Latest total liabilities as of June 2025: NT$4.81 Billion TWD
Based on the latest financial reports, Revivegen Co., Ltd. (7578) has total liabilities worth NT$4.81 Billion TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Revivegen Co., Ltd. - Total Liabilities Trend (2020–2024)
This chart illustrates how Revivegen Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Revivegen Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Revivegen Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Island Pharmaceuticals Ltd
AU:ILA
|
Australia | AU$336.43K |
|
Spring Valley Acquisition Corp. II Class A Ordinary Shares
NASDAQ:SVII
|
USA | $5.87 Million |
|
ORIENTBIO Inc.
KO:002630
|
Korea | ₩12.53 Billion |
|
Yibitas Yozgat Isci Birligi Insaat Malzemeleri Ticaret Sanayi AS
IS:YBTAS
|
Turkey | TL17.78 Million |
|
Bumyang Construction Co Ltd
KO:002410
|
Korea | ₩183.17 Billion |
|
Asri Karya Lestari Tbk.
JK:ASLI
|
Indonesia | Rp75.70 Billion |
|
Malaysia Marine and Heavy Engineering Holdings Bhd
KLSE:5186
|
Malaysia | RM1.64 Billion |
|
Value Line Inc
NASDAQ:VALU
|
USA | $42.45 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Revivegen Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Revivegen Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Revivegen Co., Ltd. (2020–2024)
The table below shows the annual total liabilities of Revivegen Co., Ltd. from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$3.94 Billion | +100.96% |
| 2023-12-31 | NT$1.96 Billion | +131.22% |
| 2022-12-31 | NT$846.98 Million | +81.18% |
| 2021-12-31 | NT$467.48 Million | +13.51% |
| 2020-12-31 | NT$411.84 Million | -- |